HUTCHMED (China) 株価情報 (NASDAQ: HCM)

HUTCHMED (China) (NASDAQ:HCM) 株価情報

HUTCHMED (China)

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China) Ltd

HCM ACQUISITION CORP USD CL A ORD SHS

HCM ACQUISITION CORP USD UNITS CONSISTING ONE CL A ORD SH OF $0.0001 PAR VALUE &

HCM ACQUISITION CORP USD RED WTS

HEALTHIER CHOICES MGMT by Healthier Choices Management Corp.

Healthier Choices Management Corp

Holcim Ltd

Direxion Shares ETF Trust Direxion HCM Tactical Enhanced US ETF

Operational and Financial Highlights for the Three Months Ended December 31, 2024
<figure class="table"> 
<table>
<tbody>
<tr>
<td>2024Q4</td>
<td>2024Q3</td>
<td>2024Q2</td>
<td>2024Q1</td>
<td>2023Q4</td>
<td>2023Q3</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Total deliveries</td>
<td>91,507</td>
<td>46,533</td>
<td>30,207</td>
<td>21,821</td>
<td>60,158</td>
<td>40,008</td>
</tr>
</tbody>
</table>
</figure>
<ul>
<li>Total deliveries of vehicles were 91,507 for the fourth quarter of 2024, representing an increase of 52.1% from 60,158 in the corresponding period of 2023. &nbsp;</li>
</ul>

Earnings

News

XPEV

XPeng's Q4 Vehicle Deliveries Surged 52.1% Year-Over-Year To 91,507 Units, While Full-Year Deliveries Climbed 34.2% To 190,068 Vehicles

Offerings

VNET

VNET Closes $430M Convertible Senior Notes Offering Due 2030

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) with a Buy and lowers the price target from $15 to $14.

Price Target

Analyst Ratings

HSCS

Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $14

Contracts

KBR Bags $229M Contract For US Army Cargo Helicopter Systems

On Monday, March 17, U.S. markets closed in green as investors bought beaten-down shares after weeks of losses. Factory activity in New York dropped sharply, and homebuilder sentiment fell due to rising costs from tariffs.
Investors are now focused on the Federal Reserve&#8217;s meeting Wednesday, where interest rates are expected to remain unchanged.
According to economic data, U.S. retail sales rose by 0.2% in February, below the expected 0.6% increase. New York&#8217;s manufacturing index dropped to -20.0, its lowest since May 2023, and homebuilder confidence fell to 39 in March from 42 in February.
Most S&amp;P 500 sectors closed higher on Monday, led by real estate, energy, and consumer staples, while consumer discretionary stocks declined.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Dow Jones Industrial Average rose 0.85% to close at 41,841.63, the S&amp;P 500 gained 0.64% to 5,675.12, and the Nasdaq Composite increased 0.31% to 17,808.66.
Asia Markets Today
<ul>
<li>On Tuesday, Japan&#8217;s Nikkei 225 rose 1.24% to 37,859.00, led by gains in the Power, Rubber and Chemical, Petroleum &amp; Plastic sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 was up 0.08% and closed at 7,860.40, led by gains in the Utilities, Gold and A-REITs sectors.</li>
<li>India&#8217;s Nifty 50 rose 1.29% to 22,800.35 and Nifty 500 was up 1.66% at 20,624.05.</li>
<li>China&#8217;s Shanghai Composite declined 0.11% to 3,429.76, and the Shanghai Shenzhen CSI 300 rose 0.27% to 4,007.72.</li>
<li>Hong Kong&#8217;s Hang Seng rallied up 2.46%, ending the session at 24,740.57.</li>
</ul>
Eurozone at 05:45 AM ET
<ul>
<li>The European STOXX 50 was up 0.93%.</li>
<li>Germany&#8217;s DAX gained 1.32%.</li>
<li>France&#8217;s CAC rose 0.64%.</li>
<li>U.K.&#8217;s FTSE 100 index traded higher by 0.50%</li>
</ul>
Commodities at 05:45 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 1.48% at $68.35/bbl, and Brent was up 1.36% at $72.04/bbl.</li>
<li>Oil prices edged up, supported by Middle East tensions and China&#8217;s stimulus plans. However, gains were limited by global growth concerns, U.S. tariffs, and Ukraine ceasefire uncertainty.</li>
<li>Natural Gas declined 0.95% to $3.980.</li>
<li>Gold clocked an all-time high of $3,037. At the time of writing, it was trading higher by 0.82% at $3,030.46, Silver was up 1.32% to $34.763, and Copper rose 0.41% to $4.9795.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were down 0.02%, S&amp;P 500 futures fell 0.02% and Nasdaq 100 futures declined 0.10%.
Forex at 05:45 AM ET
<ul>
<li>The U.S. dollar index slid 0.08% to 103.33, the USD/JPY rose 0.40% to 149.81, and the USD/AUD rose 0.01% to 1.5664.</li>
<li>The U.S. dollar edged lower Tuesday ahead of the Fed meeting, while the euro rose on Germany&#8217;s stimulus hopes. The yen slipped before the BOJ decision, and China&#8217;s yuan held steady.</li>
</ul>
Photo via Shutterstock

Asia

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Gains, Gold Makes New High - Global Markets Today While US Slept

Lee Jae-yong, Chairman of Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>), has urged the company&#8217;s executives to adopt a &#8220;death-defying&#8221; mindset to tackle the challenges posed by the artificial intelligence (AI) era.
What Happened: Lee, in a video message, addressed to around 2,000 executives of Samsung&#8217;s affiliates underscored the need for a strategic shift in the company&#8217;s approach, drawing on the management philosophies of&nbsp;late founding Chairman Lee Byung-chul&nbsp;and former Chairman Lee Kun-hee, as reported by&nbsp;<a href="https://www.koreatimes.co.kr/www/tech/2025/03/129_394287.html">The Korea Times</a>. Lee, however,&nbsp;did not appear in the&nbsp;video himself.
&#8220;Samsung&nbsp;is facing a do-or-die survival&nbsp;issue. We need to reflect&nbsp;deeply from the top,&#8221;&nbsp;Lee reportedly stated in the video. He emphasized the urgency of the situation and the need to invest in the future, even at the cost of immediate profits.
As part of the seminar, executives received a crystal plaque the size of a business card, engraved with the words: &#8220;Samsung&nbsp;people who are strong in&nbsp;crisis, good at reversal and&nbsp;fierce in competition,&#8221; reinforcing the company&#8217;s&nbsp;call for resilience. 
SEE ALSO: <a href="https://www.benzinga.com/general/space/25/03/44370917/nasa-astronauts-sunita-williams-and-butch-willmore-head-back-to-earth-on-spacex-dragon-capsule">NASA Astronauts Sunita Williams And Butch Willmore Head Back To Earth On SpaceX Dragon Capsule</a>
Why It Matters: This call for a strategic shift comes at a crucial time for Samsung. Samsung has&nbsp;been dealing with challenges&nbsp;in the AI semiconductor sector,&nbsp;especially&nbsp;in high bandwidth memory (HBM),&nbsp;where it lags behind its competitor&nbsp;SK Hynix Inc. Simultaneously, the Trump administration&#8217;s aggressive tariffs created uncertainty for Samsung&#8217;s mobile and consumer businesses.
Meanwhile, Chinese news portal Ijiwei reported that Samsung has chosen to suspend future investments in Mexico due to uncertainties surrounding Trump&#8217;s proposed tariffs.
Samsung&#8217;s <a href="https://www.benzinga.com/news/earnings/25/01/43382010/samsung-q4-earnings-12-revenue-growth-closes-gap-with-apple-in-premium-phones-eyes-ai-powered-growth-in-2025" target="_blank" rel="noreferrer noopener">fourth-quarter revenue</a>&nbsp;climbed 12% to 75.8 trillion Korean won ($52.2 billion). However, due to market conditions, operating profit declined by 30% quarter-on-quarter to 6.5 trillion Korean won ($4.48 billion).
Earlier this year,&nbsp;<a href="https://www.benzinga.com/news/management/25/02/43440540/samsungs-jay-y-lee-acquitted-shifting-focus-to-business-challenges">Lee was acquitted</a>&nbsp;of fraud and stock-rigging charges, removing a significant legal obstacle as Samsung navigates business challenges. 
READ MORE:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44343816/why-charlie-munger-never-sold-a-single-costco-share-the-billionaire-investor-called-himself-a-total-addict-of-the-store">Why Charlie Munger Never Sold A Single Costco Share—The Billionaire Investor Called Himself A &#8216;Total Addict&#8217; Of The Store</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

SSNLF

Samsung Chairman Urges Execs To Embrace 'Death-Defying' Mindset Amid AI Challenges, Says Company Is 'Facing A Do-Or-Die' Issue

Shares of Harrow, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) rose sharply in pre-market trading after the company reported fourth quarter and year-end 2024 unaudited preliminary financial results and <a href="https://www.benzinga.com/quote/HROW/earnings">issued 2025 revenue guidance</a>.
Harrow shares jumped 23.1% to $28.70 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 45.7% to $26.96 in pre-market trading after jumping over 46% on Monday.</li>
<li>Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) rose 30.4% to $0.7985 in pre-market trading. Bon Natural Life shares dipped 57% on Monday after the company announced the pricing of a $12 million offering of 8,333,332 shares at $1.44/share.</li>
<li>Genprex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>) gained 19.2% to $0.4774 in pre-market trading following a 10% surge on Monday.</li>
<li>Canopy Growth Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) gained 17.8% to $1.39 in pre-market trading after jumping 7% on Monday.</li>
<li>Arbe Robotics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBE#NASDAQ">ARBE</a>) gained 15% to $1.46 in pre-market after gaining 4% on Monday.</li>
<li>Key Tronic Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTCC#NASDAQ">KTCC</a>) gained 14.2% to $3.05 in pre-market trading.</li>
<li>FinVolution Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINV#NYSE">FINV</a>) rose 11% to $10.12 following fourth-quarter results.</li>
<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) rose 9.3% to $14.10 in pre-market trading after gaining 3% on Monday.</li>
<li>Grab Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) gained 6.3% to $4.73 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Avenue Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXI#NASDAQ">ATXI</a>) shares fell 40.3% to $0.5250 in pre-market trading.</li>
<li>Bakkt Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) fell 29.4% to $9.05 in pre-market trading after gaining 7% on Monday.</li>
<li>Hyperfine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>) dipped 25.8% to $0.95 in pre-market trading following fourth-quarter results.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) declined 24.3% to $0.1280 in pre-market trading.</li>
<li>AGM Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) fell 24.1% to $0.0802 in pre-market trading after dipping over 6% on Monday.</li>
<li>AirNet Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTE#NASDAQ">ANTE</a>) shares tumbled 18.5% to $1.31 in pre-market trading. AirNet Technology shares jumped 98% on Monday after the company announced the execution of a non-binding investment LOI with LLP STH Corp, a Kazakstan company.</li>
<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) shares fell 13.1% to $0.2469 in pre-market trading. CEL-SCI announced the pricing of $2.56 million best-efforts offering of 16 million shares of common stock.</li>
<li>Arlo Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>) shares dipped 9.3% to $10.01 in pre-market trading after gaining 4% on Monday.</li>
<li>Hallador Energy Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNRG#NASDAQ">HNRG</a>) fell 6.8% to $10.70 in today's pre-market trading following a fourth-quarter sales miss.</li>
<li>Verastem, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>) fell 6% to $6.80 in pre-market trading after gaining 4% on Monday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44355158/jim-cramer-says-this-tech-stock-is-a-meme-stock-recommends-buying-accenture">Jim Cramer Calls This Stock A &#8216;Meme Stock,&#8217; Recommends Buying Accenture</a></li>
</ul>

Pre-Market Outlook

Movers

Trading Ideas

AGMH

ANTE

ARBE

ARLO

ATXI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

Flowco Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOC#NYSE">FLOC</a>) reported quarterly earnings of $2.23 per share which beat the analyst consensus estimate of $0.32 by 596.88 percent. The company reported quarterly sales of $185.99 million which missed the analyst consensus estimate of $198.60 million by 6.35 percent.

Earnings Beats

Earnings Misses

FLOC

Flowco Holdings Q4 EPS $2.23 Beats $0.32 Estimate, Sales $185.99M Miss $198.60M Estimate

XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) reported quarterly losses of RMB(1.47) per share which missed the analyst consensus estimate of RMB(1.35) by 8.89 percent. This is a 25.76 percent increase over losses of RMB(1.98) per share from the same period last year. The company reported quarterly sales of RMB16.11 billion which beat the analyst consensus estimate of RMB16.02 billion by 0.54 percent. This is a 23.45 percent increase over sales of RMB13.05 billion the same period last year.

XPeng Q4 2024 Adj EPS RMB(1.47) Misses RMB(1.35) Estimate, Sales RMB16.11B Beat RMB16.02B Estimate

BEKE

KE Holdings Q4 Adjusted EPADS $0.16, Net Revenues $4.3B

An investor who opened a massive $517 million short position on Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) with a 40x leverage closed all their trades Tuesday, profiting millions of dollars.
What happened: The position was <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44370144/record-breaking-517-million-bitcoin-short-placed-by-influential-whale-analyst-says-the-investor-isnt-dumb">opened at an entry pric</a>e of $83,898 on the perpetual trading platform Hyperliquid, and would have been liquidated had Bitcoin reached $85,557.
However, none of the trader's perpetual futures contracts were <a href="https://hypurrscan.io/address/0xf3f496c9486be5924a93d67e98298733bb47057c">active</a> as of this writing, suggesting that the bets were closed.&nbsp;
The whale walked away with total profits of $9.46 million, with over $4 million in the last three days alone.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44363340/crypto-leaders-step-up-pressure-on-sec-as-trumps-policies-reshape-regulatory-landscape">Crypto Leaders Step Up Pressure On SEC As Trump&#8217;s Policies Reshape Regulatory Landscape</a>
Popular on-chain tracking platform Spot On Chain confirmed these findings, adding that the whale bought $6.11 million in Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) following the exit.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The "50x ETH" whale has closed its <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> short position, earning a $4.06M profit in just 3 days! Notably, the whale deposited 17.82M <a href="https://twitter.com/search?q=%24USDC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$USDC</a> to <a href="https://twitter.com/hashtag/Hyperliquid?src=hash&amp;ref_src=twsrc%5Etfw">#Hyperliquid</a> as margin over the past 3 days, mainly to short <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> (40x leverage). Just now, it closed all perp positions and withdrew… <a href="https://t.co/iE2SsoHNlX">https://t.co/iE2SsoHNlX</a> <a href="https://t.co/GUboaCp0KC">pic.twitter.com/GUboaCp0KC</a>
&mdash; Spot On Chain (@spotonchain) <a href="https://twitter.com/spotonchain/status/1901907274186235971?ref_src=twsrc%5Etfw">March 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The profitable closure of the highly leveraged short bet raised speculation that Bitcoin could reach $85,000 and beyond.
Meanwhile, the percentage of traders positioned long on Bitcoin surpassed bearish bets, <a href="https://www.coinglass.com/LongShortRatio">according </a>to data from Coinglass.
The apex cryptocurrency has dumped over 14% in the previous month, and more than 23% since its all-time highs set nearly two months ago.&nbsp;
Price Action: At the time of writing, Bitcoin was exchanging hands at $83,248.11, down 0.39% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Benzinga Note: Leverage trading allows cryptocurrency traders to open larger positions using borrowed capital. While it can potentially amplify profits, it also significantly increases the risk of substantial losses due to the volatile nature of the cryptocurrencies.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44363871/peter-schiff-slams-bitcoin-etfs-calls-selling-gold-for-btc-worst-timed-trade-in-history">Peter Schiff Slams Bitcoin ETFs, Calls Selling Gold For BTC &#8216;Worst-Timed Trade In History&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Record-Breaking Bitcoin Short Worth $517 Million Closed By Whale: Is A BTC Rally Incoming?

ZKH Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZKH#NYSE">ZKH</a>) reported quarterly earnings of $0.01 per share. This is a 83.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $324.70 million in sales this quarter. This is a 5.67 percent decrease over sales of $344.22 million the same period last year.

ZKH Group Q4 Adj $0.01 Down From $0.06 YoY, Sales $324.70M Down From $344.22M YoY

Keefe, Bruyette &amp; Woods analyst Vasundhara Govil upgrades Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) from Market Perform to Outperform and lowers the price target from $87 to $80.

Upgrades

Keefe, Bruyette & Woods Upgrades Block to Outperform, Lowers Price Target to $80

Just days ahead of its expected unveiling, Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) subsidiary Google&#8217;s Pixel 9a has appeared in full in hands-on video reviews, revealing the budget phone's refreshed design and upgraded specs.
What Happened: Two YouTubers, Sahil Karoul and The Mobile Central, posted in-depth video reviews of what appears to be the Pixel 9a, showcasing the device from every angle.
The leaks confirm earlier rumors, including a flatter back design that eliminates the prominent camera bump seen in previous models. The Pixel 9a also sports a 6.3-inch display with noticeable bezels and houses a significantly larger 5,100mAh battery.
The videos highlight camera samples captured with the phone's rumored 48-megapixel main camera, 13-megapixel ultrawide sensor, and 13-megapixel front-facing camera.
See Also: <a href="https://www.benzinga.com/25/02/43646615/top-analyst-says-metas-ai-push-could-add-100-per-share-while-tesla-faces-ev-headwindswhy-hes-still-bullish-on-musks-robotics-vision">Meta&#8217;s AI Push Could Add $100 Per Share While Tesla Faces EV Headwinds: Top Analyst</a>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Exclusive Google Pixel 9a Unboxing with Benchmark &#x7C;&#x7C; Camera shots&#x7C;&#x7C; Gameplay &#x7C;&#x7C; Speaker &amp; Display" width="500" height="281" src="https://www.youtube.com/embed/S64oWRtVOA0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
While daytime shots appear sharp and vibrant, The Mobile Central noted a dip in video quality under low-light conditions.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Pixel 9A Review: Is Google&#039;s Budget Phone Worth It?" width="500" height="281" src="https://www.youtube.com/embed/tnrLSRT7CR0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
According to the available reports, Google is expected to officially unveil the Pixel 9a on March 19, with multiple color options including purple, pink, black, and white.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It's Important: With Google's <a href="https://in.benzinga.com/25/02/43479274/alphabet-q4-earnings-highlights-ai-cloud-youtube-momentum-continues-capex-guidance-sends-shares-lower">device and subscription revenue</a> hitting $11.6 billion in the fourth quarter—up from $10.8 billion a year prior—Pixel phones remain a growing part of the company's hardware strategy.
Alphabet reported $96.5 billion in total revenue for the fourth quarter, reflecting a 12% increase from the previous year. However, this figure fell slightly short of the Street consensus estimate of $96.6 billion.
Last month, Google also announced that its <a href="https://in.benzinga.com/25/02/43649987/google-io-2025-officially-set-for-may-20-21-heres-what-to-expect-from-ai-breakthroughs-to-the-future-of-android-and-pixel-9a">annual developer conference</a>, Google I/O 2025, will be held on May 20-21 at the Shoreline Amphitheater in Mountain View, California.
There were also speculations that Google would debut the Pixel 9a at the event. While the company has traditionally launched its Pixel "a" series at I/O, in 2024 it deviated from this pattern by unveiling the Pixel 8a through a marketing campaign instead.
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/media/25/02/43646042/elon-musks-97-4-billion-openai-takeover-bid-reportedly-not-received-by-chatgpt-parent-another-one-of-his-tactics-says-sam-altman">Elon Musk's $97.4 Billion OpenAI Takeover Bid Reportedly Not Received By ChatGPT Parent: ‘Another One Of His Tactics,' Says Sam Altman</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

GOOG

GOOGL

Google Pixel 9a Leaks In Hands-On Videos Before Launch: Flat Design, 48MP Camera, 5,100mAh Battery Revealed

On Monday, Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) disclosed the launch of its Electron rocket, deploying five satellites <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44369244/successful-rocket-lab-launch-completes-deployment-of-full-kin-is-constellation-in-less-than-a-year" rel="noreferrer noopener">for French IoT operator Kinéis</a>.
This marks the completion of a five-launch deal, delivering Kinéis&#8217; 25-satellite constellation to Low Earth Orbit in under a year.
Rocket Lab founder and CEO Peter Beck said, &#8220;Many constellation operators wait years for their first mission, but we&#8217;ve deployed Kinéis&#8217; mission in under a year and with 100% dedicated launches where they have been able to select launch site, date, and orbital parameters allowing them to maximize coverage for each of their 25 spacecraft.&#8221;
Christophe Vassal &#8211; Chairman of the Supervisory Board of Kinéis, said, &#8221;On June 1st, we will launch our IoT satellite connectivity commercial services. This achievement marks the beginning of a new era for Kinéis, where the data collected by our constellation will unlock numerous opportunities for our clients and partners.&#8221;
Last week, Rocket Lab USA launched two software solutions&nbsp;to enhance the efficiency <a target="_blank" href="https://www.benzinga.com/25/03/44298251/rocket-lab-launches-next-gen-software-platforms-for-space-missions" rel="noreferrer noopener">of space mission operations</a>.
Investors can gain exposure to the stock via ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) and Tidal ETF Trust II Pinnacle Focused Opportunities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCUS#NYSE">FCUS</a>).
Price Action: RKLB shares are up 0.89% at $19.27 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44349255/rocket-lab-launches-lightning-god-reigns-mission-for-japans-iqps-sets-sights-on-high-five-launch-just-three-days-later" target="_blank" rel="noreferrer noopener">Rocket Lab Launches &#8216;Lightning God Reigns&#8217; Mission, Sets Sights On &#8216;High Five&#8217; Launch Just Three Days Later</a></li>
</ul>
Image via Shutterstock.

Equities

Large Cap

ARKX

FCUS

RKLB

Rocket Lab Launches Final Kinéis Satellite, Enabling Global IoT Coverage

Goldman Sachs analyst Brooke Roach upgrades Ralph Lauren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) from Neutral to Buy and raises the price target from $280 to $286.

Goldman Sachs Upgrades Ralph Lauren to Buy, Raises Price Target to $286

Billionaire investor David Tepper&#8217;s bullish call on Chinese stocks has yielded significant returns, with Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) shares rallying 40.44% since his Sep. 26 declaration that he was <a href="https://www.benzinga.com/markets/asia/24/12/42692036/billionaire-investors-michael-burry-david-tepper-could-benefit-from-chinas-stimulus-measures">buying &#8220;everything&#8221; in China</a>.
What Happened: BABA shares closed Monday at $147.57, up 4.59%, representing a substantial gain from $105.07 when Tepper made his bold prediction. The hedge fund manager cited exceptionally low valuations and China&#8217;s fiscal stimulus plans as key factors <a href="https://www.benzinga.com/markets/asia/24/12/42692036/billionaire-investors-michael-burry-david-tepper-could-benefit-from-chinas-stimulus-measures">behind his investment thesis</a>.
Regulatory filings show Appaloosa Management increased its stakes in major Chinese e-commerce names during the fourth quarter of 2024, with Alibaba remaining among the fund&#8217;s largest holdings. 
The firm also boosted positions in PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), JD.Com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), and China-focused ETFs including iShares China Large-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>) and KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>).
&#8220;When that came in, we got a little bit longer&#8230; more Chinese stocks,&#8221; Tepper said in September on CNBC&#8217;s &#8220;Squawk Box,&#8221; revealing he had exceeded his usual 10-15% allocation limits for Chinese investments.
While BABA has outperformed, performance has varied across Tepper&#8217;s China investments. JD.com has climbed 19% since September, but PDD Holdings declined 0.38% during the same period.
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44370649/ross-gerber-says-tesla-chair-robyn-denholm-paid-off-to-do-nothing-only-represents-elon-musk-while-pocketing-682-million">Ross Gerber Says Tesla Chair Robyn Denholm Paid Off To Do Nothing: &#8216;Only Represents&#8217; Elon Musk While Pocketing $682 Million</a>
Why It Matters: China&#8217;s economy beat forecasts with 5.4% growth in the fourth quarter of 2024, supported by Beijing&#8217;s stimulus measures including interest rate cuts. Investors now await details on additional fiscal support targeting consumer demand and <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41050711/stocks-rise-as-china-signals-more-stimulus-billionaire-david-tepper-bets-big-on-everythi">the troubled real estate market</a>.
Concerns remain about deflation and the potential impact of President Donald Trump&#8216;s 10% <a href="https://www.benzinga.com/personal-finance/25/03/44360075/retail-giant-target-which-relies-on-china-for-30-of-its-merchandise-warns-of-profit-hit-as-trumps-trade-war-bites">tariffs on Chinese imports</a>. Beijing has responded with targeted retaliatory duties, vowing to protect its interests against what it calls &#8220;bullying.&#8221;
Tepper isn&#8217;t alone in his China optimism. Michael Burry&#8216;s Scion Asset Management has also established significant positions in Chinese tech companies, with Alibaba representing 16.36% of the fund&#8217;s total investments, according to <a href="https://www.benzinga.com/markets/equities/25/02/43878703/institutional-investors-load-up-on-technology-and-financial-stocks-in-q4-while-reducing-positions-in-healthcare-sector-amid-political-uncertainty">recent 13F filings</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44212672/jamie-dimon-cashed-out-234-million-in-jpmorgan-stock-warren-buffett-stockpiled-334-billion-in-cash-weeks-later-markets-crashed-coincidence" target="_blank" rel="noreferrer noopener">Jamie Dimon Cashed Out $234 Million In JPMorgan Stock, Warren Buffett Stockpiled $334 Billion In Cash — Weeks Later, Markets Crashed. Coincidence?</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

BABA

KWEB

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Billionaire Investor David Tepper's 'Everything' China Bet Pays Off With Alibaba Up 40% Since September

Evercore ISI Group analyst Daniel Markowitz initiates coverage on Bio-Techne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECH#NASDAQ">TECH</a>) with a Outperform rating and announces Price Target of $75.

Initiation

TECH

Evercore ISI Group Initiates Coverage On Bio-Techne with Outperform Rating, Announces Price Target of $75

Elbit Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $1.95 by 36.41 percent. This is a 70.51 percent increase over earnings of $1.56 per share from the same period last year. The company reported quarterly sales of $1.93 billion which beat the analyst consensus estimate of $1.78 billion by 8.44 percent. This is a 18.78 percent increase over sales of $1.63 billion the same period last year.

ESLT

Elbit Systems Q4 2024 Adj EPS $2.66 Beats $1.95 Estimate, Sales $1.93B Beat $1.78B Estimate

President Donald Trump has publicly praised Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) founder&nbsp;and owner of The Washington&nbsp;Post, Jeff Bezos, for the significant changes he has implemented at the newspaper.
What Happened: President Trump,&nbsp;during an interview with television&nbsp;journalist Sharyl Attkisson, expressed his appreciation for Bezos&#8217; efforts to improve The Washington Post. &#8220;I&nbsp;think a guy like Bezos&nbsp;is — I've gotten to&nbsp;know him, and I think&nbsp;he's trying to do a&nbsp;real job. Jeff Bezos is&nbsp;trying to do a real&nbsp;job with The Washington Post,&#8221; Trump said.
Trump acknowledged a shift in Bezos&#8217; management of the Post during his first term, a change he claims was not previously evident. His comments refer to a series of high-profile decisions Bezos has made at the newspaper, including discontinuation of editorial support for a presidential candidate last fall, implementing a new directive for op-eds, and restructuring the Post&#8217;s newsroom. These changes have sparked significant backlash, leading to canceled subscriptions, staff departures, and accusations that Bezos is seeking to gain favor with Trump to further his business interests. Bezos has dismissed these claims, asserting that the changes at the Post are essential for regaining reader trust. SEE ALSO: <a href="https://www.benzinga.com/25/03/44370387/fed-put-on-standby-while-trump-put-may-be-kaput-analysts-expect-jerome-powell-to-pivot-to-a-measured-stance-amid-economic-uncertainty">Fed Put On Standby, While Trump Put May Be Kaput? Analysts Expect Jerome Powell To Pivot To A Measured Stance Amid Economic Uncertainty </a> Why It Matters: Bezos&#8217; overhaul of The Washington Post has been a topic of controversy. In February, the <a href="https://www.benzinga.com/25/02/43760885/jeff-bezos-owned-washington-post-turns-down-ad-campaign-that-asked-whos-running-this-country-donald-trump-or-elon-musk">newspaper rejected a provocative</a> "Fire Elon Musk" ad campaign by advocacy group Common Cause. This decision was part of a larger shift in the newspaper&#8217;s editorial policy. Also in February, Bezos, who attended Trump&#8217;s inauguration, announced a significant shift in the newspaper's opinion section, <a href="https://www.benzinga.com/general/social-media/25/02/43997193/jeff-bezos-washington-post-overhaul-draws-oligarch-remark-from-bernie-sanders-elon-musk-calls-amazon-founder-a-bravo">prioritizing viewpoints</a> supporting free markets and personal liberties. This move has drawn both praise and criticism, with some accusing Bezos of using the newspaper to advance his personal and business interests. Former Labor Secretary Robert Reich condemned this move as he said, &#8220;..it's not a win for free speech. It's a win for oligarchy." On the other hand, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk, responded to this move on X with "Bravo, Jeff Bezos!"
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="President Trump says immigration, the economy and the war in Ukraine are all on his short list." width="500" height="281" src="https://www.youtube.com/embed/Y16M67qNot8?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
READ MORE:
<ul>
<li><a href="https://www.benzinga.com/25/03/44370877/trump-ally-larry-ellisons-oracle-pledges-5-billion-to-boost-uks-ai-driven-cloud-infrastructure">Trump Ally Larry Ellison&#8217;s Oracle Pledges $5 Billion To Boost UK&#8217;s AI-Driven Cloud Infrastructure</a></li>
</ul>
Image via Shutterstock Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Politics

AMZN

TSLA

Trump Praises Jeff Bezos' Recent Moves With Washington Post: 'He's Trying To Do A Real Job'

Health Care

Press Releases

HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer

Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer

HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients After Disease Progression on EGFR Inhibitor Therapy

HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib)

Financing

HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture

HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy

HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC

HUTCHMED to Announce 2024 Final Results

Management

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

HUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in China

Comments

HUTCHMED (China)

ニュース

パートナーシップ

ベンジンガ・グローバル